These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34734015)

  • 1. Caseinolytic protease P (CLPP) activated by ONC201 inhibits proliferation and promotes apoptosis in human epithelial ovarian cancer cells by inducing mitochondrial dysfunction.
    Kou X; Ding H; Li L; Chao H
    Ann Transl Med; 2021 Sep; 9(18):1463. PubMed ID: 34734015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSPA8-mediated stability of the CLPP protein regulates mitochondrial autophagy in cisplatin-resistant ovarian cancer cells.
    Kou X; Yang X; Zhao Z; Li L
    Acta Biochim Biophys Sin (Shanghai); 2024 Mar; 56(3):356-365. PubMed ID: 38419499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer.
    Fan Y; Wang J; Fang Z; Pierce SR; West L; Staley A; Tucker K; Yin Y; Sun W; Kong W; Prabhu V; Allen JE; Zhou C; Bae-Jump VL
    Front Oncol; 2022; 12():789450. PubMed ID: 35372029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ClpP regulates breast cancer cell proliferation, invasion and apoptosis by modulating the Src/PI3K/Akt signaling pathway.
    Luo J; Zeng B; Tao C; Lu M; Ren G
    PeerJ; 2020; 8():e8754. PubMed ID: 32195060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer.
    Wu Y; You Y; Chen L; Liu Y; Liu Y; Lou W; Fu F
    Gland Surg; 2022 Apr; 11(4):687-701. PubMed ID: 35531115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues.
    Graves PR; Aponte-Collazo LJ; Fennell EMJ; Graves AC; Hale AE; Dicheva N; Herring LE; Gilbert TSK; East MP; McDonald IM; Lockett MR; Ashamalla H; Moorman NJ; Karanewsky DS; Iwanowicz EJ; Holmuhamedov E; Graves LM
    ACS Chem Biol; 2019 May; 14(5):1020-1029. PubMed ID: 31021596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMP075 targeting ClpP for colon cancer therapy in vivo and in vitro.
    Zhang J; Luo B; Sui J; Qiu Z; Huang J; Yang T; Luo Y
    Biochem Pharmacol; 2022 Oct; 204():115232. PubMed ID: 36030831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro.
    Chen L; Liu T; Zhang S; Zhou J; Wang Y; Di W
    J Ovarian Res; 2014 Dec; 7():115. PubMed ID: 25491408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis.
    Greer YE; Hernandez L; Fennell EMJ; Kundu M; Voeller D; Chari R; Gilbert SF; Gilbert TSK; Ratnayake S; Tang B; Hafner M; Chen Q; Meerzaman D; Iwanowicz E; Annunziata CM; Graves LM; Lipkowitz S
    Cancer Res Commun; 2022 Oct; 2(10):1144-1161. PubMed ID: 36388465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA growth arrest-specific transcript 5 is involved in ovarian cancer cell apoptosis through the mitochondria-mediated apoptosis pathway.
    Gao J; Liu M; Zou Y; Mao M; Shen T; Zhang C; Song S; Sun M; Zhang S; Wang B; Zhu D; Li P
    Oncol Rep; 2015 Dec; 34(6):3212-21. PubMed ID: 26503132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
    Ma Z; Wang X; He J; Xia J; Li Y
    PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancer.
    Fennell EMJ; Aponte-Collazo LJ; Pathmasiri W; Rushing BR; Barker NK; Partridge MC; Li YY; White CA; Greer YE; Herring LE; Lipkowitz S; Sumner SCJ; Iwanowicz EJ; Graves LM
    Front Pharmacol; 2023; 14():1136317. PubMed ID: 37063293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B; Yang S; Liu T; Lou G
    Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Caseinolytic Protease P: A Possible Novel Prognostic Marker and Therapeutic Target in Cancer.
    Cormio A; Sanguedolce F; Pesce V; Musicco C
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLPP inhibition triggers apoptosis in human ovarian granulosa cells
    Yuan X; Ma W; Chen S; Wang H; Zhong C; Gao L; Cui Y; Pu D; Tan R; Wu J
    Front Genet; 2023; 14():1141167. PubMed ID: 37007963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
    Zhang C; Li Y; Zhao W; Liu G; Yang Q
    Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
    Xu JH; Wang Y; Xu D
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ONC201-Induced Mitochondrial Dysfunction, Senescence-like Phenotype, and Sensitization of Cultured BT474 Human Breast Cancer Cells to TRAIL.
    Mishukov A; Odinokova I; Mndlyan E; Kobyakova M; Abdullaev S; Zhalimov V; Glukhova X; Galat V; Galat Y; Senotov A; Fadeev R; Artykov A; Gasparian ME; Solovieva M; Beletsky I; Holmuhamedov E
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
    Ma SY; Wei P; Qu F
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.